Matches in SemOpenAlex for { <https://semopenalex.org/work/W3213814777> ?p ?o ?g. }
- W3213814777 abstract "The coronavirus disease 2019 (COVID-19) has spread worldwide since early 2020, and there are still no signs of resolution. The Japanese Clinical Practice Guidelines for the Management of Sepsis and Septic Shock (J-SSCG) 2020 Special Committee created the Japanese rapid/living recommendations on drug management for COVID-19 using the experience of creating the J-SSCG.The Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) approach was used to determine the certainty of the evidence and strength of the recommendations. The first edition of this guideline was released on September 9, 2020, and this document is the revised edition (version 4.0; released on September 9, 2021). Clinical questions (CQs) were set for the following seven drugs: favipiravir (CQ1), remdesivir (CQ2), corticosteroids (CQ4), tocilizumab (CQ5), anticoagulants (CQ7), baricitinib (CQ8), and casirivimab/imdevimab (CQ9). Two CQs (hydroxychloroquine [CQ3] and ciclesonide [CQ6]) were retrieved in this updated version.Favipiravir is not suggested for all patients with COVID-19 (GRADE 2C). Remdesivir is suggested for patients with moderate COVID-19 requiring supplemental oxygen/hospitalization (GRADE 2B). Corticosteroids are recommended for patients with moderate COVID-19 requiring supplemental oxygen/hospitalization (GRADE 1B) and for patients with severe COVID-19 requiring mechanical ventilation/intensive care (GRADE 1A); however, their administration is not recommended for patients with mild COVID-19 not requiring supplemental oxygen (GRADE 1B). Tocilizumab is suggested for patients with moderate COVID-19 requiring supplemental oxygen/hospitalization (GRADE 2B). Anticoagulant administration is recommended for patients with moderate COVID-19 requiring supplemental oxygen/hospitalization and patients with severe COVID-19 requiring mechanical ventilation/intensive care (good practice statement). Baricitinib is suggested for patients with moderate COVID-19 requiring supplemental oxygen/hospitalization (GRADE 2C). Casirivimab/imdevimab is recommended for patients with mild COVID-19 not requiring supplemental oxygen (GRADE 1B). We hope that these updated clinical practice guidelines will help medical professionals involved in the care of patients with COVID-19." @default.
- W3213814777 created "2021-11-22" @default.
- W3213814777 creator A5003857215 @default.
- W3213814777 creator A5004342411 @default.
- W3213814777 creator A5012888329 @default.
- W3213814777 creator A5013726912 @default.
- W3213814777 creator A5014765734 @default.
- W3213814777 creator A5016846250 @default.
- W3213814777 creator A5024738150 @default.
- W3213814777 creator A5032342136 @default.
- W3213814777 creator A5041347997 @default.
- W3213814777 creator A5046816913 @default.
- W3213814777 creator A5050533134 @default.
- W3213814777 creator A5052226149 @default.
- W3213814777 creator A5053891527 @default.
- W3213814777 creator A5061102458 @default.
- W3213814777 creator A5066466748 @default.
- W3213814777 creator A5068933649 @default.
- W3213814777 creator A5079036022 @default.
- W3213814777 creator A5081009970 @default.
- W3213814777 creator A5081383438 @default.
- W3213814777 creator A5084473249 @default.
- W3213814777 creator A5087956208 @default.
- W3213814777 date "2021-01-01" @default.
- W3213814777 modified "2023-10-06" @default.
- W3213814777 title "Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (September 2021)" @default.
- W3213814777 cites W2472937910 @default.
- W3213814777 cites W2505867792 @default.
- W3213814777 cites W2531269403 @default.
- W3213814777 cites W2884033130 @default.
- W3213814777 cites W2952092758 @default.
- W3213814777 cites W2970684805 @default.
- W3213814777 cites W3018023298 @default.
- W3213814777 cites W3027630905 @default.
- W3213814777 cites W3048223030 @default.
- W3213814777 cites W3048510827 @default.
- W3213814777 cites W3080718665 @default.
- W3213814777 cites W3081721922 @default.
- W3213814777 cites W3081877184 @default.
- W3213814777 cites W3082108964 @default.
- W3213814777 cites W3087214787 @default.
- W3213814777 cites W3093604087 @default.
- W3213814777 cites W3093837118 @default.
- W3213814777 cites W3094197937 @default.
- W3213814777 cites W3094609299 @default.
- W3213814777 cites W3098266159 @default.
- W3213814777 cites W3102015759 @default.
- W3213814777 cites W3107151174 @default.
- W3213814777 cites W3110466220 @default.
- W3213814777 cites W3110844195 @default.
- W3213814777 cites W3111431752 @default.
- W3213814777 cites W3113196149 @default.
- W3213814777 cites W3121693389 @default.
- W3213814777 cites W3122987078 @default.
- W3213814777 cites W3129869280 @default.
- W3213814777 cites W3130126061 @default.
- W3213814777 cites W3131580109 @default.
- W3213814777 cites W3134383271 @default.
- W3213814777 cites W3134507486 @default.
- W3213814777 cites W3159501004 @default.
- W3213814777 cites W3170605968 @default.
- W3213814777 cites W4206449744 @default.
- W3213814777 cites W4210642183 @default.
- W3213814777 doi "https://doi.org/10.1002/ams2.706" @default.
- W3213814777 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8594767" @default.
- W3213814777 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34815889" @default.
- W3213814777 hasPublicationYear "2021" @default.
- W3213814777 type Work @default.
- W3213814777 sameAs 3213814777 @default.
- W3213814777 citedByCount "13" @default.
- W3213814777 countsByYear W32138147772022 @default.
- W3213814777 countsByYear W32138147772023 @default.
- W3213814777 crossrefType "journal-article" @default.
- W3213814777 hasAuthorship W3213814777A5003857215 @default.
- W3213814777 hasAuthorship W3213814777A5004342411 @default.
- W3213814777 hasAuthorship W3213814777A5012888329 @default.
- W3213814777 hasAuthorship W3213814777A5013726912 @default.
- W3213814777 hasAuthorship W3213814777A5014765734 @default.
- W3213814777 hasAuthorship W3213814777A5016846250 @default.
- W3213814777 hasAuthorship W3213814777A5024738150 @default.
- W3213814777 hasAuthorship W3213814777A5032342136 @default.
- W3213814777 hasAuthorship W3213814777A5041347997 @default.
- W3213814777 hasAuthorship W3213814777A5046816913 @default.
- W3213814777 hasAuthorship W3213814777A5050533134 @default.
- W3213814777 hasAuthorship W3213814777A5052226149 @default.
- W3213814777 hasAuthorship W3213814777A5053891527 @default.
- W3213814777 hasAuthorship W3213814777A5061102458 @default.
- W3213814777 hasAuthorship W3213814777A5066466748 @default.
- W3213814777 hasAuthorship W3213814777A5068933649 @default.
- W3213814777 hasAuthorship W3213814777A5079036022 @default.
- W3213814777 hasAuthorship W3213814777A5081009970 @default.
- W3213814777 hasAuthorship W3213814777A5081383438 @default.
- W3213814777 hasAuthorship W3213814777A5084473249 @default.
- W3213814777 hasAuthorship W3213814777A5087956208 @default.
- W3213814777 hasBestOaLocation W32138147771 @default.
- W3213814777 hasConcept C126322002 @default.
- W3213814777 hasConcept C142724271 @default.
- W3213814777 hasConcept C177713679 @default.
- W3213814777 hasConcept C194828623 @default.
- W3213814777 hasConcept C2777178219 @default.